USPTO serial 79445256
INNOPEUTICS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 29, 2026
- Examiner
- LAM, HAI-LY HUYNH
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with INNOPEUTICS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kwang Yup Chae
Kwang Yup Chae Hauptman Ham, LLPSuite 14002318 Mill RoadAlexandria, VA 22314Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of musculoskeletal disorders; Pharmaceutical preparations for the treatment of multiple sclerosis; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of leukemia; Pharmaceutical preparations for the treatment of cells, namely, pharmaceutical preparations for cellular therapy for the treatment of autoimmune diseases, and pharmaceutical preparations for cellular therapy for the treatment of cancer; Cardiovascular pharmaceutical preparations; Pharmaceutical preparations for the prevention of disorders of the nervous system; Pharmaceutical preparations for treating malignant tumours; Pharmaceutical preparations for the treatment of viral and infectious diseases and for the treatment of cancer; Biopharmaceuticals for the treatment of cancer; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of inflammatory diseases; Biotechnological preparations for medical purposes, namely, for the treatment of immunological disorders; Pharmaceutical compositions for the treatment of genetic, neurological, cardiovascular, and metabolic diseases; Pharmaceuticals for the treatment of neurodegenerative disease, namely, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and neuropathy pain; pharmaceutical preparations for the treatment of auto-immune diseases; Pharmaceutical preparations for the treatment of tumours; Pharmaceutical preparations for the treatment of central nervous system diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 29, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 29, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 11, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 11, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 5, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 13, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 2, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 2, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 2, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 2, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 29, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jun 29, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 29, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jun 29, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jun 29, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jun 5, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 5, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 24, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 23, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 21, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 23, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 23, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 23, 2026 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Mar 5, 2026 | SDRC | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | — |